{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:44:27Z","timestamp":1782902667045,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3403200"],"award-info":[{"award-number":["2023YFC3403200"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0329"],"award-info":[{"award-number":["2022YFS0329"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21018"],"award-info":[{"award-number":["ZYJC21018"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFTD0029"],"award-info":[{"award-number":["2024NSFTD0029"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.136922","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T07:16:14Z","timestamp":1730099774000},"page":"136922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Identification of c.146G\u00a0&gt;\u00a0A mutation in a Fabry patient and its correction by customized Cas9 base editors in vitro"],"prefix":"10.1016","volume":"282","author":[{"given":"Zhi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0005","first-page":"91","article-title":"Enzyme replacement therapy in Fabry disease in Poland: a position statement","volume":"130","author":"Nowicki","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136922_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0004.2009.01166.x","article-title":"A successful screening for Fabry disease in a Chinese dialysis patient population","volume":"76","author":"Lv","year":"2009","journal-title":"Clin. Genet."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136922_bb0015","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3390\/ijms22126518","article-title":"Human alpha-galactosidase a mutants: priceless tools to develop novel therapies for Fabry disease","volume":"22","author":"Modrego","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.136922_bb0020","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.3390\/ijms221810088","article-title":"Pathogenesis and molecular mechanisms of Anderson-Fabry disease and possible new molecular addressed therapeutic strategies","volume":"22","author":"Tuttolomondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136922_bb0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10157-011-0486-1","article-title":"Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new alpha-galactosidase mutation of Leu311Arg (L311R)","volume":"15","author":"Suzuki","year":"2011","journal-title":"Clin. Exp. Nephrol."},{"issue":"Suppl. 2","key":"10.1016\/j.ijbiomac.2024.136922_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ndt\/gfab038","article-title":"Precision medicine in Fabry disease","volume":"36","author":"Lenders","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136922_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2174\/1570159X20666220601124117","article-title":"Fabry disease: current and novel therapeutic strategies. A Narrative Review","volume":"21","author":"Palaiodimou","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136922_bb0040","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41436-019-0451-z","article-title":"Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study","volume":"21","author":"Germain","year":"2019","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136922_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"J. Med. Genet."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136922_bb0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/humu.21530","article-title":"A pharmacogenetic approach to identify mutant forms of alpha-galactosidase a that respond to a pharmacological chaperone for Fabry disease","volume":"32","author":"Wu","year":"2011","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136922_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.semperi.2018.09.003","article-title":"CRISPR\/Cas9 gene-editing: research technologies, clinical applications and ethical considerations","volume":"42","author":"Memi","year":"2018","journal-title":"Semin. Perinatol."},{"issue":"679","key":"10.1016\/j.ijbiomac.2024.136922_bb0060","doi-asserted-by":"crossref","first-page":"eadd4666","DOI":"10.1126\/scitranslmed.add4666","article-title":"Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons","volume":"15","author":"Qian","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136922_bb0065","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","article-title":"Rescue of Fragile X Syndrome Neurons by DNA methylation editing of the FMR1 gene","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136922_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41551-023-01007-3","article-title":"Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington\u2019s disease","volume":"7","author":"Yan","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","article-title":"dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice","volume":"28","author":"Colasante","year":"2020","journal-title":"Mol. Ther."},{"issue":"7603","key":"10.1016\/j.ijbiomac.2024.136922_bb0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/j.ijbiomac.2024.136922_bb0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of a*T to G*C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136922_bb0090","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/nar\/gkm238","article-title":"SNAP: predict effect of non-synonymous polymorphisms on function","volume":"35","author":"Bromberg","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2024.136922_bb0095","doi-asserted-by":"crossref","first-page":"W446","DOI":"10.1093\/nar\/gkab266","article-title":"MutationTaster2021","volume":"49","author":"Steinhaus","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136922_bb0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.136922_bb0105","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-021-00835-9","article-title":"CADD-splice-improving genome-wide variant effect prediction using deep learning-derived splice scores","volume":"13","author":"Rentzsch","year":"2021","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0115","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1038\/s41467-020-19669-x","article-title":"Inferring the molecular and phenotypic impact of amino acid variants with MutPred2","volume":"11","author":"Pejaver","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.136922_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2018.02.021","article-title":"Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ","volume":"481","author":"Ferri","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136922_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nbt.3528","article-title":"Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch","volume":"34","author":"Oakes","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.136922_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122089","article-title":"Using CRISPR\/Cas9-mediated GLA gene knockout as an in vitro drug screening model for Fabry disease","volume":"17","author":"Song","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136922_bb0135","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.ekir.2023.08.027","article-title":"Loss-of-function homozygous variant in LPL causes type I Hyperlipoproteinemia and renal Lipidosis","volume":"8","author":"Wu","year":"2023","journal-title":"Kidney Int. Rep."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2024.136922_bb0140","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136922_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000472202","article-title":"Fabry disease: fourteen alpha-galactosidase a mutations in unrelated families from the United Kingdom and other European countries","volume":"4","author":"Davies","year":"1996","journal-title":"Eur. J. Hum. Genet.\u202f: EJHG"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136922_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/humu.1219","article-title":"Fabry disease: 20 novel GLA mutations in 35 families","volume":"18","author":"Blaydon","year":"2001","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136922_bb0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/3.4.667","article-title":"Detection of 8 new mutations in the alpha-galactosidase a gene in Fabry disease","volume":"3","author":"Davies","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2024.136922_bb0160","doi-asserted-by":"crossref","unstructured":"D.P. Germain, J. Shabbeer, S. Cotigny, R.J. Desnick, Fabry Disease: Twenty Novel Alpha-Galactosidase a Mutations and Genotype-Phenotype Correlations in Classical and Variant Phenotypes, Molecular Medicine (Cambridge, Mass.) vol. 8(6) (2002) 306\u201312.","DOI":"10.1007\/BF03402156"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136922_bb0165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/FPC.0b013e32830500f4","article-title":"Prediction of response of mutated alpha-galactosidase a to a pharmacological chaperone","volume":"18","author":"Shin","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"issue":"W1","key":"10.1016\/j.ijbiomac.2024.136922_bb0170","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","article-title":"ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules","volume":"44","author":"Ashkenazy","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136922_bb0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136922_bb0180","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0185","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41467-017-01496-2","article-title":"Structural insights into DNA cleavage activation of CRISPR-Cas9 system","volume":"8","author":"Huai","year":"2017","journal-title":"Nat. Commun."},{"issue":"6408","key":"10.1016\/j.ijbiomac.2024.136922_bb0190","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.aas9129","article-title":"Engineered CRISPR-Cas9 nuclease with expanded targeting space","volume":"361","author":"Nishimasu","year":"2018","journal-title":"Science"},{"issue":"7699","key":"10.1016\/j.ijbiomac.2024.136922_bb0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/cpps.20","article-title":"Comparative protein structure modeling using MODELLER","volume":"86","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Protein Sci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.136922_bb0205","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jmb.2017.12.007","article-title":"A completely Reimplemented MPI bioinformatics toolkit with a new HHpred server at its Core","volume":"430","author":"Zimmermann","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.108","article-title":"Protein sequence analysis using the MPI bioinformatics toolkit","volume":"72","author":"Gabler","year":"2020","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0215","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41467-018-08034-8","article-title":"Engineering of high-precision base editors for site-specific single nucleotide replacement","volume":"10","author":"Tan","year":"2019","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.136922_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","article-title":"Fabry\u2019s disease","volume":"344","author":"El-Abassi","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136922_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ijbiomac.2024.136922_bb0230","series-title":"Comprehensive Clinical Nephrology","author":"Johnson","year":"2018"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136922_bb0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s10038-019-0599-z","article-title":"Mutation spectrum of alpha-galactosidase gene in Japanese patients with Fabry disease","volume":"64","author":"Kobayashi","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136922_bb0240","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000079244","article-title":"Comparative in vitro expression study of four Fabry disease causing mutations at glutamine 279 of the alpha-galactosidase a protein","volume":"57","author":"Dominissini","year":"2004","journal-title":"Hum. Hered."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136922_bb0245","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/abbi.2000.1743","article-title":"Role of Ser-65 in the activity of alpha-galactosidase a: characterization of a point mutation (S65T) detected in a patient with Fabry disease","volume":"377","author":"Ishii","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase a in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136922_bb0255","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gim.2016.122","article-title":"The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat","volume":"19","author":"Benjamin","year":"2017","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136922_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BCJ20190513","article-title":"Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease","volume":"477","author":"Seemann","year":"2020","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0265","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-021-21371-5","article-title":"Lentivirus-mediated gene therapy for Fabry disease","volume":"12","author":"Khan","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.136922_bb0270","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/j.ymthe.2021.03.018","article-title":"ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic alpha-gal a activity and effective substrate reduction in Fabry mice","volume":"29","author":"Pagant","year":"2021","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136922_bb0275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/crispr.2020.0144","article-title":"Rationally Designed Base editors for precise editing of the sickle cell disease mutation","volume":"4","author":"Chu","year":"2021","journal-title":"CRISPR J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0280","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/s41467-020-18715-y","article-title":"Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing","volume":"11","author":"Nguyen Tran","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136922_bb0285","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.7150\/thno.70869","article-title":"Internally inlaid SaCas9 base editors enable window specific base editing","volume":"12","author":"Jiang","year":"2022","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136922_bb0290","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI61852","article-title":"Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts","volume":"122","author":"Moiani","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136922_bb0295","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/mt.2014.3","article-title":"Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo","volume":"22","author":"Cesana","year":"2014","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136922_bb0300","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI61852","article-title":"Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts","volume":"122","author":"Moiani","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.136922_bb0305","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic Cancer after gene therapy for cerebral Adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.136922_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713202","article-title":"Applications and research advances in the delivery of CRISPR\/Cas9 Systems for the Treatment of inherited diseases","volume":"24","author":"Lu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136922_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41597-020-00794-7","article-title":"A catalogue of 863 Rett-syndrome-causing MECP2 mutations and lessons learned from data integration","volume":"8","author":"Ehrhart","year":"2021","journal-title":"Sci. Data"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024077316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024077316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:51:10Z","timestamp":1782899470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024077316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":63,"alternative-id":["S0141813024077316"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136922","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of c.146G\u00a0>\u00a0A mutation in a Fabry patient and its correction by customized Cas9 base editors in vitro","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"136922"}}